WO2024240727 - SALTS OF AMINO QUINAZOLINE DERIVATIVES
National phase entry:
Publication Number
WO/2024/240727
Publication Date
28.11.2024
International Application No.
PCT/EP2024/063878
International Filing Date
21.05.2024
Title **
[English]
SALTS OF AMINO QUINAZOLINE DERIVATIVES
[French]
SELS DE DÉRIVÉS D'AMINO QUINAZOLINE
Applicants **
CHIESI FARMACEUTICI S.P.A.
Inventors
AMADEI, Francesco
DE ANGELIS, Davide
BASSANETTI, Irene
OSBOURN, Susan Elizabeth
CARR, Andrew David
MARI, Massimiliano
Priority Data
23174497.0
22.05.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2456 | |
| EPO | Filing, Examination, Granting | 13604 | |
| Japan | Filing, Examination, Granting | 2468 | |
| South Korea | Filing, Examination, Granting | 2759 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
26,627
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
-(1-(5-methyl-1,2,4- oxadiazol-3-yl)ethyl)quinazolin-4-amine, pharmaceutical compositions containing them and therapeutic use thereof. The salts of the invention may be useful in the treatment of diseases or conditions associated with respiratory diseases, in particular chronic cough.[French]
-(1-(5-méthyl-1,2,4-oxadiazol-3-yl)éthyl) quinazolin-4-amine, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les sels selon l'invention peuvent être utiles dans le traitement de maladies ou d'états associés à des maladies respiratoires, en particulier la toux chronique.